Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2026-04-30 18:33:04 ET · period of report 2026-04-28 · accession 0001532218-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-04-30 18:33 | 2026-04-28+ | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $13.45 | +508.3K | 2,141 | New | +$6.84M |
| DMT | 2026-04-30 18:33 | 2026-04-28+ | KNSA | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $51.96 | -508.3K | 0 | -100% | -$26.42M |
| DMT | 2026-04-30 18:33 | 2026-04-28+ | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $0.00 | -508.3K | 48.6K | -91% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2026-04-28 | M | A | 431,904 | $10.36 | 431,904 | D | — | — | (F1) This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025. |
| 2 | Common | Class A Ordinary Share | 2026-04-28 | M | A | 51,750 | $30.93 | 483,654 | D | — | — | (F1) This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025. |
| 3 | Common | Class A Ordinary Share | 2026-04-28 | S | D | 74,635 | $50.43 | 409,019 | D | — | — | (F1) This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025. (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $50.00 and $50.985. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 4 | Common | Class A Ordinary Share | 2026-04-28 | S | D | 113,673 | $51.47 | 295,346 | D | — | — | (F1) This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025. (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $51.00 and $51.99. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 5 | Common | Class A Ordinary Share | 2026-04-28 | S | D | 243,596 | $52.02 | 51,750 | D | — | — | (F1) This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025. (F4) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $52.00 and $52.58. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 6 | Common | Class A Ordinary Share | 2026-04-28 | S | D | 51,750 | $54.02 | 0 | D | — | — | (F1) This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025. (F5) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $54.00 and $54.22. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 7 | Common | Class A Ordinary Share | 2026-04-29 | M | A | 22,544 | $30.93 | 22,544 | D | — | — | (F1) This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025. |
| 8 | Common | Class A Ordinary Share | 2026-04-29 | S | D | 22,544 | $54.01 | 0 | D | — | — | (F1) This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025. (F6) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $54.00 and $54.225. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 9 | Common | Class A Ordinary Share | 2026-04-30 | M | A | 2,141 | $30.93 | 2,141 | D | — | — | (F1) This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025. |
| 10 | Common | Class A Ordinary Share | 2026-04-30 | S | D | 2,141 | $54.01 | 0 | D | — | — | (F1) This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025. (F7) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $54.00 and $54.03. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 11 | Derivative | Share Option | 2026-04-28 | M | D | 431,904 | $0.00 | 0 | D | $10.36 · — to 2028-02-29 | 431,904 Class A Ordinary Share | (F1) This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025. (F8) The option is fully vested and exercisable. |
| 12 | Derivative | Share Option | 2026-04-28 | M | D | 51,750 | $0.00 | 73,250 | D | $30.93 · — to 2028-09-19 | 51,750 Class A Ordinary Share | (F1) This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025. (F8) The option is fully vested and exercisable. |
| 13 | Derivative | Share Option | 2026-04-29 | M | D | 22,544 | $0.00 | 50,706 | D | $30.93 · — to 2028-09-19 | 22,544 Class A Ordinary Share | (F1) This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025. (F8) The option is fully vested and exercisable. |
| 14 | Derivative | Share Option | 2026-04-30 | M | D | 2,141 | $0.00 | 48,565 | D | $30.93 · — to 2028-09-19 | 2,141 Class A Ordinary Share | (F1) This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on October 31, 2025. (F8) The option is fully vested and exercisable. |